Go Back

SHAPOS SERVICES PRIVATE LIMITED

ReshaMandi

U74110KA2020PTC134121

Get Comprehensive Report

₹1,999.00 ₹3,998.00
Suggest Edit Last updated: Jan 17, 2025
Key Metrics
  • No. of Employees467
  • Founded Year 2020
  • Company StagePrivate Limited Company
  • Total Funding₹429.92 Cr
  • Industry

  • Headquarter
  • Company StatusActive
About ReshaMandi
India’s first and largest B2B marketplace digitizing the natural fibre supply chain. ReshaMandi provides a full-stack digital ecosystem in the form of a super app, from FARM to RETAIL.
Business Model

ReshaMandi is a B2B marketplace that digitizes the natural fibre supply chain, providing a full-stack digital ecosystem from farm to retail in the form of a super app. They also offer quality testing, technical advisory, high-quality inputs, and market linkages at every node of the natural fibre supply chain to organize the global natural fibre supply chain.

Top Competitors
GR
GreenikkU74999KL2020PTC061162
ReshaMandi Funding Details
Funding Highlights
Latest Funding RoundDebt Financing
Total Funding Raised₹429.92 Cr
No. of Investments Made0
Total No. of Acquisitions1
Lead Investors3
Investors
  • Creation Investments, Omnivore, STRIVE
Funding Details
TheKredible's detailed funding report contains info about Funding raised by the company along with Lead Investors, Investors, Shareholding Strcuture, and its Investments & Acquisitions.
₹799.00 ₹1,598.00
Funding History
TheKredible's 'Funding History' report provides deep insights of Funding with list of Lead Investors
₹399.00 ₹798.00
Funding Per Year
A Funding report of the company's overall funding on yearly basis, segregated by the team TheKredible.
₹199.00 ₹398.00
Acquisition Company Done
Detailed report about the Acquistions the company has done till date.
₹499.00 ₹998.00
ReshaMandi Financial Details
Financial Highlights
FY 2021-22 Revenue₹415.65 Cr
FY 2021-22 Expenses₹474.28 Cr
FY 2021-22 Profit/Loss-₹58.62 Cr
Net Cash Flow From Operations-₹152.05 Cr
Full Financial Details
Detailed report containing info about Business Model, year-wise Financial Comparison, Ratio Analysis and detailed Revenue and Expense breakdowns.
₹799.00 ₹1,598.00
Financial Comparison
A detailed report of year-wise Financial Comparison of the company
₹430.00 ₹860.00
Revenue Breakdown
A report and breakdown of the company's year-wise revenue streams.
₹399.00 ₹798.00
Expense Breakdown
A report and breakdown of the company's year-wise expenditures.
₹399.00 ₹798.00
Shareholding Structure
Team at TheKredible has gone through several ROC filings and portrayed Shareholding Structure of the company.
₹499.00 ₹998.00
Financial Ratio
Analysis of Financial Ratios which gives quick insights about the company's profitability and capital efficiency.
₹199.00 ₹398.00
ReshaMandi Key People
People Metrics
Current Core Team2
Board Members/Directors4

Core Team

SA
Saurabh Agarwal Co-Founder & CTO
MT
Mayank TiwariCo Founder & CEO

Board Members/Directors

SA
Saurabh AgarwalDirector
JT
John Tyler DayNominee Director
MT
Mayank TiwariDirector
NP
Natasha PantDirector
ReshaMandi Documents

AY - 2020-21

Profit and Loss statement - ReshaMandi - 2020-21.pdf
TheKredible's experts has summarized the Profit and Loss Statement of ReshaMandi for FY 2020-21.
₹249.00 ₹498.00
Balance Sheet - ReshaMandi - 2020-21.pdf
TheKredible's experts has summarized the Balance Sheet of ReshaMandi for FY 2020-21.
₹249.00 ₹498.00

AY - 2021-22

Profit and Loss statement - ReshaMandi - 2021-22.pdf
TheKredible's experts has summarized the Profit and Loss Statement of ReshaMandi for FY 2021-22.
₹249.00 ₹498.00
Balance Sheet - ReshaMandi - 2021-22.pdf
TheKredible's experts has summarized the Balance Sheet of ReshaMandi for FY 2021-22.
₹249.00 ₹498.00

Subscribe to our newsletter to stay updated

Weekly Funding Reports
Funding Report
Weekly Funding Report [14 Apr - 19 Apr, 2025]
Monthly Funding Reports
Funding Report
Indian startup funding declines over 50% in Februa...

Get your Customised Report

With an exclusive 20% off on your order

Latest Industry Reports
Industry Report
HealthTech’s Rebound: After a Downturn, HealthTech...